MOS
MRNA icon

MGO One Seven’s Moderna MRNA Stock Holding History

MGO One Seven’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221K Buy
+3,153
New +$163K ﹤0.01% 1431
2024
Q4 		– Sell
-3,051
Closed -$204K – 1109
2024
Q3 		$204K Sell
3,051
-328
-10% -$30.1K 0.01% 929
2024
Q2 		$401K Sell
3,379
-11
-0.3% -$1.39K 0.02% 645
2024
Q1 		$361K Buy
3,390
+136
+4% +$13.7K 0.02% 664
2023
Q4 		$324K Buy
3,254
+1,495
+85% +$126K 0.02% 681
2023
Q3 		$182K Buy
+1,759
New +$196K 0.01% 763
2021
Q4 		– Sell
-724
Closed -$250K – 687
2021
Q3 		$250K Sell
724
-326
-31% -$120K 0.03% 502
2021
Q2 		$247K Buy
+1,050
New +$188K 0.03% 498

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

MGO One Seven's MRNA Position: Q2 2026 in Review

MGO One Seven opened a new position in Moderna (MRNA) in Q2 2026: 3,153 shares worth $221K. The stake represents ﹤0.01% of the portfolio and ranks #1431 among its holdings. This is a return to the name: MGO One Seven previously reported a position in MRNA as recently as Q3 2024.

MGO One Seven first reported a position in MRNA in Q2 2021 and has held it in 8 quarters since. The position peaked at $401K in Q2 2024. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • MGO One Seven held 3,153 shares of Moderna worth $221K as of Q2 2026.
  • Moderna was a new MGO One Seven position in Q2 2026.
  • Moderna made up ﹤0.01% of MGO One Seven's portfolio in Q2 2026, its #1431 holding.
  • MGO One Seven first reported a position in Moderna in Q2 2021 and has held it in 8 quarters since.
  • MGO One Seven's Moderna position peaked at $401K in Q2 2024.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.